Home/Filings/4/0001829126-23-008139
4//SEC Filing

Leider Harry L. 4

Accession 0001829126-23-008139

CIK 0001557376other

Filed

Dec 19, 7:00 PM ET

Accepted

Dec 20, 4:05 PM ET

Size

5.2 KB

Accession

0001829126-23-008139

Insider Transaction Report

Form 4
Period: 2023-12-19
Leider Harry L.
DirectorChief Executive Officer
Transactions
  • Sale

    Common Stock

    2023-12-19$1.31/sh5,248$6,9010 total(indirect: See footnote)
Footnotes (1)
  • [F1]The shares disposed of were held by the Harry L. Leider Revocable Trust of which the Reporting Person is the Trustee.

Issuer

Organicell Regenerative Medicine, Inc.

CIK 0001557376

Entity typeother

Related Parties

1
  • filerCIK 0001888273

Filing Metadata

Form type
4
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 4:05 PM ET
Size
5.2 KB